SYNBIO TECHNOLOGIES INC.

Company Overview

Synbio Technologies develops and markets products and services for DNA reading, writing, and editing. Products and services include NGS, Sanger sequencing, and immunosequencing (DNA reading); gene synthesis, cloning, pathway/genome synthesis, synthetic DNA libraries (DNA writing); and CRISPR-Cas9 sgRNA design, library construction, and genome editing (DNA editing).

Synbio’s Synotype platform is an integrated system for translation or reverse translation between genotype and phenotype. The company has expertise in synthetic biology technologies, including DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, pharmacogenomics, microbiology, and translational biology.

Synbio Technologies’ shall help the DNA data storage ecosystem by manufacturing (i.e., synthesizing the digitalized DNA that will be used in storage) and working to develop efficient algorithms that will help expedite the translation from digital information into DNA.

In July 2017, Synbio partnered with Twist Bioscience to supply long-length genes. Twist will manufacture synthetic DNA up to 3.2 kb in length, and supply it to Synbio, which will create genes up to 70 kb in length. This alliance provided Twist with an entry into the China market.

Company's Business Segments

• Synthetic Biology : The company provides highly accurate and cost-effective synthetic biology products and services for researchers globally.